Chief Medical Officer · Cullinan Therapeutics, Inc. (CGEM)

Jon Wigginton

FY2020 is the first fiscal year CompBrief holds for Jon Wigginton as a named executive officer of Cullinan Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$4,544,022

Salary $321,122Stock awards $0Bonus $258,000

4th of 5 named executive officers at Cullinan Therapeutics by FY2020 total.

5 named officers on file for Cullinan Therapeutics, FY2020

Jon Wigginton’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Cullinan Therapeutics’s whole pay program stands against its peers

  • Cullinan Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CGEM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2021 (DEF 14A).

Free

Get Jon Wigginton’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Jon Wigginton compensation by year

Cullinan Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Cullinan Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020
Salary$321,122
Bonus$258,000
Stock awards$0
Option awards$3,959,525
Non-equity incentive$0
Pension and deferred compensation$0
All other$5,375
Total$4,544,022

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cullinan Therapeutics, Inc. DEF 14A filed April 29, 2021, accession 0001193125-21-140630, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cullinan Therapeutics, Inc. filed document, accession 0001193125-21-140630. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2021.

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option252,891—$4.30
Option379,337—$4.30

Per the Outstanding Equity Awards at Fiscal Year-End table in Cullinan Therapeutics, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Cullinan Therapeutics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Owen HughesChief Executive Officer$6,552,058
Patrick BauerleActing Chief Scientific Officer, Biologics$5,353,497
Patrick BaeuerleActing Chief Scientific Officer$5,353,496
Jon Wigginton · this pageChief Medical Officer$4,544,022
Jeffrey TrigilioChief Financial Officer$1,737,685

The full Cullinan Therapeutics compensation record

free company brief

This page is one person within Cullinan Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cullinan Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jon Wigginton's compensation dossier · One-time report. No refunds.